News

Erivedge capsule, taken orally once-a-day, is the first FDA-approved medicine for people with advanced forms of the most common skin cancer. The approval is based on results from

Hydrochlorothiazide Capsules, 12.5mg, indicated for the management of hypertension, is therapeutically equivalent to the reference listed drug, Microzide Capsules, 12.5mg, of Watson Pharmaceuticals. The company is expected to

Posidur is a post-operative pain relief depot that utilizes Durect’s patented Saber technology to deliver bupivacaine and is designed to provide up to three days of pain relief

The company has enrolled more than 600 patients in the randomized, placebo-controlled, parallel-group environmental study. The double-masked study is evaluating the safety and efficacy of the combination nasal

The company plans to retrofit 19,000sqft of space for product development and analytical laboratories. The remaining 13,000sqft will accommodate future expansion. Watson Pharmaceuticals intends to initially invest approximately

The collaboration will utilize KineMed’s Dynamic Proteomics technology platform to map the impact of potential drug candidates on specific metabolic pathways. KineMed R&D executive vice-president Scott Turner said

The newly approved drug provides a new, single-tablet treatment option, taken twice-daily, for patients who need to control their blood sugar. Jentadueto is a prescription medication used along

The patent application includes 30 claims covering composition of matter and formulations of MC3, as well as methods of using these compositions and formulations. This second generation LNP

Pharmacy Xpert, which is a part of the Clinical Xpert Suite of workflow solutions, is a clinical intelligence dashboard that aids hospital pharmacists in eliminating medication errors and